Cytek Biosciences, Inc. CTKB Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Cytek Biosciences, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s asset turnover?
- Cytek Biosciences, Inc. (CTKB) reported asset turnover of 0.4× in Q1 2026.
- How has Cytek Biosciences, Inc.'s asset turnover changed year-over-year?
- Cytek Biosciences, Inc.'s asset turnover increased by 8.4% year-over-year, from 0.4× to 0.4×.
- What is the long-term trend for Cytek Biosciences, Inc.'s asset turnover?
- Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s asset turnover has grown at a 2.9% compound annual growth rate (CAGR), from 0.4× to 0.4×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.